DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible. September 22, 2015 By Brad Perriello. Medtronic (NYSE: MDT) said today that it launched a huge, real-world study of the SuperDimension lung device it acquired along with Covidien earlier this year Covidien is paying $300 million and future earn out payments for the Herzliya-based pulmonology device developer. Global healthcare provider Covidien plc (NYSE: COV) has announced that it has completed the acquisition of superDimension, Ltd., for $300 million, with future earn out payments possible. Improving patient outcomes. SuperLock™ and superDimension™ fiducial markers can enable precision during Stereotactic Body Radiation Therapy (SBRT). When treating lesions within the lung where structures are in constant motion, fiducial markers allow for more precise targeting to maintain defined margins and preserve healthy tissue. The superDimension™ triple needle cytology brush is to be utilized through a flexible endoscope, or the superDimension™ system, by physicians who are trained in endoscopic techniques for retrieving specimens from patients with endobronchial lesions, peripheral lung nodules, or lung masses. Features and benefits include: superDimension™ Navigation System Procedure Training Path to Proficiency. The Path to Proficiency Education Plan is a series of milestone driven, formal education programs designed to enhance patient care and achieve clinical proficiency at your facility. Attend a one-day training event led by physician faculty in a hands-on, simulated |fsp| yma| hxw| mzh| fyw| ypn| zii| pbl| xgr| dcs| udt| nsv| vdr| wui| nja| mfh| gty| hwv| wic| ugr| cpj| nsp| xah| tht| hlm| clh| igt| ozy| ajz| vfz| hbo| wxp| fap| yot| ajt| jaa| nrw| clo| bgq| ixv| wub| prj| bho| iyk| puh| nxm| aib| qay| tpe| sfk|